CD4 and Parkinson disease: However, they are not prone to MPTP-induced neurodegeneration when they receive CD4+ T lymphocytes from D3R-deficient mice [127]. DRD3 expression in lymphocytes is reduced in Parkinson disease patients and correlates with disease severity, possibly due to changes in D3R density in other lymphocyte populations.